We are live on
!
Find out more
PTC
Philadelphia Trust Company Portfolio holdings
AUM
$1.42B
1-Year Est. Return
43.77%
This Fund
S&P 500
This Quarter
Est. Return
+10.08%
1 Year Est. Return
+43.77%
3 Year Est. Return
+141.5%
5 Year Est. Return
+176.17%
10 Year Est. Return
+554.31%
AUM
$1.45B
AUM Growth
+$150M
(+12%)
Cap. Flow
+$33.3M
Cap. Flow
% of AUM
2.3%
Top 10 Holdings %
Top 10 Hldgs %
31.97%
Holding
239
New
25
Increased
56
Reduced
99
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citizens Financial Group
CFG
|
+$17.2M |
| 2 |
Carrier Global
CARR
|
+$13.9M |
| 3 |
Goldman Sachs
GS
|
+$13.4M |
| 4 |
GAP
The Gap Inc
GAP
|
+$6.52M |
| 5 |
Skyworks Solutions
SWKS
|
+$6.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$12.7M |
| 2 |
KYNB
Kyntra Bio
KYNB
|
+$7.58M |
| 3 |
AYX
Alteryx Inc
AYX
|
+$6.92M |
| 4 |
Academy Sports + Outdoors
ASO
|
+$4.44M |
| 5 |
Newell Brands
NWL
|
+$3.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.92% |
| 2 | Healthcare | 18.54% |
| 3 | Communication Services | 13.54% |
| 4 | Financials | 12.39% |
| 5 | Industrials | 10.83% |
Similar funds
CBA
BC
KC
EWS
SCM
NI
QC
IHG
Philadelphia Trust Company's Q2 2021 Portfolio in Review
As of Q2 2021, Philadelphia Trust Company held 239 positions worth $1.45B, up 12% from $1.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Philadelphia Trust Company's Q2 2021 filing shows 25 new, 56 increased, 99 reduced and 14 closed positions. Its largest new stake was Citizens Financial Group: 363,420 shares worth $16.7M. The largest sale was Biogen, an estimated $12.7M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Communication Services.
- Philadelphia Trust Company's largest Q2 2021 buy was Citizens Financial Group: 363,420 shares worth $16.7M.
- Philadelphia Trust Company added most to Carrier Global in Q2 2021, an estimated $13.9M increase.
- Philadelphia Trust Company's biggest Q2 2021 reduction was Biogen, cutting an estimated $12.7M.
- Philadelphia Trust Company fully exited Kyntra Bio in Q2 2021, selling an estimated $7.58M.
- Philadelphia Trust Company's ten largest holdings make up 32% of its $1.45B portfolio in Q2 2021.
- Philadelphia Trust Company opened 25 new positions and closed 14 in Q2 2021.
- Philadelphia Trust Company's portfolio value rose 12% quarter-over-quarter to $1.45B.
Based on Philadelphia Trust Company's 13F filing for Q2 2021, filed 13 Aug 2021.